APA (7th ed.) Citation

Tracey, H., Bate, S. T., Ford, S., Patel, P., Bloomer, J., Patel, A., & Taskar, K. S. (2025). Matrix Approach Assessment of Cabotegravir Drug–Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling. Pharmaceutics, 17(4), 531. https://doi.org/10.3390/pharmaceutics17040531

Chicago Style (17th ed.) Citation

Tracey, Helen, Simon T. Bate, Susan Ford, Parul Patel, Jackie Bloomer, Aarti Patel, and Kunal S. Taskar. "Matrix Approach Assessment of Cabotegravir Drug–Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling." Pharmaceutics 17, no. 4 (2025): 531. https://doi.org/10.3390/pharmaceutics17040531.

MLA (9th ed.) Citation

Tracey, Helen, et al. "Matrix Approach Assessment of Cabotegravir Drug–Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling." Pharmaceutics, vol. 17, no. 4, 2025, p. 531, https://doi.org/10.3390/pharmaceutics17040531.